Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease

Thrombosis and Haemostasis

Volumn 83, Issue 6, 2000, Pages 853-860

  Gunther A ^a   Mosavi, P ^a   Ruppert, C ^a   Heinemann, S ^a   Temmesfeld, B ^a   Velcovsky, H G ^a   Morr, H ^b   Grimminger, F ^a   Walmrath, D ^a   Seeger, W ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b Klin Lungen und Bronchialheilkunde   (Germany)

Author keywords

Interstitial lung disease (ILD); PAI 1; T PA; Tissue factor; U PA

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 7; D DIMER; FIBRIN; FIBRINOPEPTIDE A; IODINE 125; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROCOAGULANT; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ADOLESCENT; ADULT; AGED; ALLERGIC PNEUMONITIS; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG ALVEOLUS; LUNG COMPLIANCE; LUNG FIBROSIS; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0343192482     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613933     Document Type: Article

References (38)

1. Idell S, James KK, Levin EG, Schwartz, BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, Fair DS. Local abnormalities in coagulation and fibrinolytyic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome. J Clin Invest 1989; 84: 695-705.
2. Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, Maunder RJ. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol 1991; 261: L240-L8.
3. Seeger W, Hübel J, Klapettek K, Pison U, Obertacke U, Joka T, Roka L. Procoagulant activity in bronchoalveoar lavage of severely traumatized patients - relation to the development of acute respiratory distress. Thromb Res 1991; 91: 45-52.
4. Chapman HA, Allen CL, Stone OL. Human alveolar macrophages synthezise factor VII in vitro. Possible role in interstitial lung disease. J Clin Invest 1985; 75: 2030-7.
5. McGee MP, Wallin R, Wheeler FB, Rothenberger H. Initiation of the extrinsic pathway of coagulation by human and rabbit alveolar macrophages: a kinetic study. Blood 1989; 74: 1583-90.
6. Gross TJ, Simon RH, Sitrin RG. Tissue factor procoagulant expression by rat alveolar epithelial cells. Am J Respir Cell Mol Biol 1992; 6: 397-403.
7. Gross TJ, Simon RH, Kelly CJ, Sitrin RG. Rat alveolar epithelial cells concomitantly express plasminogen activator inhibitor-1 and urokinase. Am J Physiol 1991; 260: L286-L95.
8. Parton LA, Warbuton D, Laug WE. Plasminogen activator inhibitor type II production by rat type II pneumocytes in culture. Am J Respir Cell Mol Biol 1992; 6: 133-9.
9. Chapman HA, Yang X, Sailor LZ, Sugarbaker DJ. Developmental expression of plasminogen activator inhibitor type I by human alveolar macrophages. Possible role in lung injury. J Immunol 1990; 145: 3398-405.
10. Idell S, Zwieb C, Boggaram J, Holiday D, Johnson AR, Raghu G. Mechanisms of fibrin formation and lysis by human lung fibroblasts: influence of TGF-β and TNF-α. Am J Physiol 1992; 263: L487-L94.
11. Idell S, James KK, Gillies C, Fair DS, Thrall RS. Abnormalities of pathways of fibrin turnover in lung lavage of rats with oleic acid and bleomycin-induced lung injury support alveolar fibrin deposition. Am J Pathol 1989; 135: 387-99.
12. Olman MA, Mackman N, Gladson CL, Moser KM, Loskutoff DJ. Changes in the procoagulant and fibrinolytic gene expression during bleomycin-induced lung injury in the mouse. J Clin Invest 1995; 96: 1621-30.
13. Perez RL, Roman J, Staton GW, Hunter RL. Extravascular coagulation and fibrinolysis in murine lung inflammation induced by the mycobacterial cord factor trehalose-6,6'-dimycolate. Am J Respir Crit Care Med 1994; 149: 510-8.
14. Sawaba M. Coagulation and fibrinolysis systems in bronchoalveolar lavage fluids in irradiated lung of rabbits. Nippon Kyobu Shikkan Gakkai Zasshi 1993; 31: 1515-21.
15. Hasday JD, Bachwich PR, Lynch III JP, Sitrin RG. Procoagulant and plasminogen activator activities of bronchoalveolar fluid in patients with pulmonary sarcoidosis. Exp Lung Res 1988; 14: 261-78.
16. de Moerloose P, De Benedetti E, Nicod L, Vifian C, Reber G. Procoagulant activitiy in bronchoalveolar fluids: no relationship with tissue factor pathway inhibitor activity. Thromb Res 1992; 65: 507-18.
17. Nakstadt B, Lyberg T, Skjonsberg OH, Boye NP. Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res 1990; 57: 827-38.
18. Kotani I, Sato A, Hayakaya H, Urano T, Takada Y, Takada A. Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb. Res 1995; 77: 493-504.
19. Robinson BWS. Production of plasminogen activator by alveolar macrophages in normal subjects and patients with interstitial lung disease. Thorax 1988; 43: 508-15.
20. 7 on alveolar T cells in interstitial lung diseases. Clin Exp Immunol 1999; 116: 340-6.
21. Günther A, Kalinowski M, Elssner A, Seeger W. Clot embedded natural surfactant: kinetics of fibrinolysis and surface activity. Am J Physiol 1994; 267: L618-24.
22. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem 1959; 37: 911-7.
23. Günther A, Siebert C, Schmidt R, Ziegler S, Grimminger F, Yabut M, Temmesfeld B, Walmrath D, Morr H, Seeger W. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema. Am J Respir Crit Care Med 1996; 153: 176-84.
24. Smith PK, Kohn RI, Hermannson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olso BJ, Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 1985; 150: 76-85.
25. Chapman HA, Bertozzi P, Sailor LZ, Nusrat R. Alveolar macrophage urokinase receptors localize enzyme activity to the cell surface. Am J Physiol 1990; 259: L432-L8.
26. Sugiyama Y, Kasahara T, Mukaida N, Matsushima K, Kitamura S. Chemokines in bronchoalveolar lavage fluid in summer-type hypersensitivity pneumonitis. Eur Respir J 1995; 8: 1084-90.
27. Nakamura H, Fujishima S, Waki Y, Urano T, Sayama K, Sakamaki F, Terashima T, Soejima K, Tasaka S, Ishizaka A. Priming of alveolar macrophages for interleukin-8 production in patients with idiopathic lung fibrosis. Am J Respir Crit Care Med 1995; 152: 1579-86.
28. Walker C, Bauer W, Braun RK, Menz G, Braun P, Schwarz F, Hansel TT, Villiger B. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia. Am J Respir Crit Care Med 1994; 150: 1038-48.
29. Hernandez-Rodriguez NA, Chambrey AD, Harrison HK, Chambers RC, Gray AJ, Southcott AM, du Bois R, Black CM, Scully MF, Anulty RJ, Laurent GJ. Role of thrombin in pulmonary fibrosis. Lancet 1995; 346 (8982): 1071-3.
30. Gray AJ, Bishop JE, Reeves JT, Mecham RP, Laurent GJ. Partially degraded fibrin(ogen) stimulates fibroblast proliferation in vitro. Am J Respir Mol Cell Biol 1995; 12: 684-90.
31. Yamada, KM. Adhesive recognition sequences. J Biol Chem 1991; 266: 12809-12.
32. Seeger W, Elssner A, Günther A, Krämer HJ, Kalinowski HO. Lung surfactant phospholipids associate with polymerizin fibrin: loss of surface activity. Am J Respir Cell Mol Biol 1993; 9: 213-20.
33. Günther A, Kalinowski M, Rosseau S, Seeger W. Surfactant incorporation markedly alters mechanical properties of a fibrin clot. Am J Respir Cell Mol Biol 1995; 13: 712-8.
34. Günther A, Kalinowski M, Elssner A, Seeger W. Clut-embedded natural surfactant: kinetics of fibrinolysis and surface activity. Am J Physiol 1994; 267: L618-L24.
35. Ruf W, Edgington TE. Structural biology of tissue factor, the initiator of thrombogenesis in vivo. Faseb J 1994; 8: 385-90.
36. Günther A, Schmidt R, Nix F, Yabut-Perez M, Guth C, Rosseau S, Sicbert C, Grimimnger F, Morr H, Velcovsky HG, Seeger W. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis. Eur Respir J 1999; 14: 565-73.
37. McDonald JA. The yin and yang of fibrin in the airways. N Engl J Med 1992; 13: 929-31.
38. Burkhardt A. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 1989; 140: 513-24.